media – Page 658 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Fortimedix launches short instruments for SymphonX single-port platform

Fortimedix Surgical said today it launched a shorter set of instruments for its SymphonX single-port surgical platform in the US.
- Source: Massdevice
- 549
- August 8, 2017
Company Insight instrument microlaparoscopic surgical
FDA extends review on Dynavax’s Heplisav-B

FDA extends review on Dynavax's hepatitis B vaccine candidate Heplisav-B, but both management and analysts said they remain confident in approval.
- Source: fiercepharm
- 633
- August 7, 2017
Company Insight FDA hepatitis Heplisav-B Market Views vaccine
Ddu to attend the FIME show

The 27th Florida International Medical Exhibition (FIME) will be held in Orlando, USA from August 8 to August 10, 2017.
- Source: Ddu
- 880
- August 7, 2017
Exhibitions & Activities FIME
Harvard University develops soft robotic arm for endoscopes

US researchers from Harvard University’s SEAS and the Wyss Institute for Biologically Inspired Engineering have developed a small, hybrid rigid-soft robotic arm for endoscopes.
- Source: medicaldevices-network.com
- 669
- August 7, 2017
endoscope Researches SEAS
CombiMatrix, Skyline Medical, Victory Square Technologies

The merger and acquisition information of CombiMatrix, Skyline Medical and Victory Square Technologies.
- Source: medicaldevices-network.com
- 393
- August 7, 2017
Company Insight M&A Market Views
2nd International Conference on Optometry and Vision Science

Meet Global optometrists from USA (Americas), Europe, Middle East and Asia Pacific at 2nd International Conference on Optometry and Visual Science happening from August 7-9, 2017 Beijing, China.
- Source: medical-events
- 619
- August 4, 2017
Exhibitions & Activities Optometry Vision Science
Roche reports strong performance in the first half of 2017

Commenting on the Group’s results, Roche CEO Severin Schwan said: “In the first half of the year, both our Pharmaceuticals and Diagnostics Divisions showed strong performance, very much driven by new product launches. Particularly pleasing is the very successful launch of Ocrevus for the treatment of two forms of multiple sclerosis. Based on our half-year performance, we raised the outlook for the full-year to mid-single digit sales growth.”
- Source: www.roche.com
- 523
- August 4, 2017
Company Insight
10th International Conference on Clinical and Surgical Ophthalmology

Location: New South Wales, Australia Venue Address: DoubleTree by Hilton Beijing 168 Guang An Men Wai Avenue Xi Cheng District Beijing China Date: 07 Aug,2017 – 09 Aug,2017 Organizer: Sarika James Brief Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. The theme of the conference is “Exploring the novel research and trends in clinical and surgical ophthalmology” which focuses on the significance of vision and also explore the spectrum of latest technological developments in the field of Ophthalmology. Ophthalmology Conference 2017 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe. Detailed Description: Conference Series LLC cordially invites you to participate at the 10th International Conference on Clinical and Surgical Ophthalmology to be held during August 07-09, 2017 at Beijing, China. ...
- Source: medical-events
- 638
- August 4, 2017
Clinical Exhibitions & Activities surgical
GSK delivers further progress in Q2 and sets out new priorities for the Group

GSK delivers further progress in Q2 and sets out new priorities for the Group
- Source: www.gsk.com/
- 384
- August 4, 2017
Company Insight
Johnson & Johnson Reports 2017 Second-Quarter Results

New Brunswick, N.J. (July 18, 2017) – Johnson & Johnson (NYSE: JNJ) today announced sales of $18.8 billion for the second quarter of 2017, an increase of 1.9% as compared to the second quarter of 2016. Operational sales results increased 2.9% and the negative impact of currency was 1.0%. Domestic sales increased 1.6%. International sales increased 2.3%, reflecting operational growth of 4.4% and a negative currency impact of 2.1%. Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 0.5%, domestic sales decreased 1.0% and international sales increased 2.0%.*
- Source: www.jnj.com
- 604
- August 4, 2017
Company Insight

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.